Muscular glycogenosis
RSS feedInitial results on the safety of home enzyme replacement therapy in Pompe disease
A Dutch survey of people with Pompe disease has assessed the safety of administering enzyme replacement therapy at home, a strategy that has been offered in the Netherlands since 2008. The results were published in May 2023: the study analysed data from 116 patients (including 82 with the adult form) receiving a home infusion of … [Read more]
The French Pompe disease registry turns 18
Created in 2004, the French registry for Pompe disease collects prospective clinical and biological data on people with this disease. In 2022, thanks to the collaboration of the 31 reference centres for rare neuromuscular and metabolic diseases, the register includes 210 patients with the adult form of the disease. One hundred and seventy-seven received enzyme … [Read more]
Low-carbohydrate ketogenic diet and McArdle’s disease: results of an international survey
An international survey of 183 people with McArdle’s disease in 18 countries, including France, was conducted to gather their experiences with the low-carbohydrate, high-fat ketogenic diet. The results show that: one third of the participants have tried this diet, among them, nearly 90% reported positive effects on McArdle’s disease symptoms (exercise intolerance, muscle pain and … [Read more]
A metabolic myopathy with a frequently poor prognosis reported in Japan
Multiple acyl-CoA dehydrogenase (MADD) deficiency is responsible for a metabolic myopathy linked to three distinct genes: ETFA, ETFB and ETFDH. Japanese researchers compiled clinical and biological data from a cohort of 37 patients with MADD. The cohort was collected from 1997 to 2020, which accounts for its relative rarity. A mutation in the ETFDH p.Y507D … [Read more]
